Another immune-related proposed mechanism of resistance to PD-1 inhibition is the propensity of tumor-related PD-1 macrophages to take up the anti-PD-1 monoclonal antibodies, even those that are already PD-1-engaged on the membrane of the PD-1+CD8+ T cells [114]; in such a scenario, the co-receptor PD-1 and PD-L1 interaction between the T and tumor cells cannot not be disrupted and the immune blockade not unleashed. Here, PDCD1 is linked to neoplasm.